Treating Women with Substance Use Disorders During Pregnancy


Book Description

This book provides a first in-depth, comprehensive, and evidenced-based overview of the treatment of substance use disorders in the pregnant patient. It provides readers with materials that will not only aid them in identifying, assessing, and understanding the issues involved in treating these women, but also the practical tools to implement the best practices from comprehensive care programs specializing in this sort of treatment. Each chapter strikes a balance between the best scientific information available and reasoned, clinical wisdom to fill in where evidence-based information is unavailable — all in a form that is practical and accessible. It is a valuable tool for clinicians and service providers across disciplines.




Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy


Book Description

These guidelines have been developed to enable professionals to assist women who are pregnant, or have recently had a child, and who use alcohol or drugs or who have a substance use disorder, to achieve healthy outcomes for themselves and their fetus or infant. They have been developed in response to requests from organizations, institutions and individuals for technical guidance on the identification and management of alcohol, and other substance use and substance use disorders in pregnant women. They were developed in tandem with the WHO recommendations for the prevention and management of tobacco use and second-hand smoke exposure in pregnancy.




Opioid-Use Disorders in Pregnancy


Book Description

Gain guidance and support when treating the high-risk population of women confronting (or battling) opioid-use disorders during pregnancy.




Treating Women with Substance Use Disorders


Book Description

Filling a crucial need, this manual presents the Women's Recovery Group (WRG), an empirically supported treatment approach that emphasizes self-care and developing skills for relapse prevention and recovery. Grounded in cognitive-behavioral therapy, the WRG is designed for a broad population of women with alcohol and drug use disorders, regardless of their specific substance of abuse, age, or co-occurring disorders. Step-by-step intervention guidelines are accompanied by 80 reproducible clinical tools, including participant handouts, session outlines, bulletin board materials, and more. The large-size format facilitates photocopying; purchasers also get access to a Web page where they can download and print the reproducible materials.







Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants


Book Description

This Guide provides comprehensive, national guidance for the optimal management of pregnant and parenting women with OUD and their infants based on the recommendations of experts reviewing the limited evidence available for this population as of 2017. In the past, only one option was available for OUD treatment in pregnant women. Today, more options are available, so healthcare professionals need to provide more education to their patients and obtain their detailed informed consent to ensure decision-making is shared between the pregnant woman or new mother and the healthcare professional. This Guide will help healthcare professionals and patients determine the most clinically appropriate action for a particular circumstance, with the expectation that the healthcare professionals will make individualized treatment decisions. A cornerstone of the Guide is that a healthy pregnancy results in a healthy infant and mother. The Guide recognizes the mother and infant as a dyad, and the recommendations are provided in light of what actions will optimize the outcomes for the mother-infant dyad as a whole, with guidance provided from preconception to several months postpartum and for the first few years of infant development.




Women and Addiction


Book Description

For many years, addiction research focused almost exclusively on men. Yet scientific awareness of sex and gender differences in substance use disorders has grown tremendously in recent decades. This volume brings together leading authorities to review the state of the science and identify key directions for research and clinical practice. Concise, focused chapters illuminate how biological and psychosocial factors influence the etiology and epidemiology of substance use disorders in women; their clinical presentation, course, and psychiatric comorbidities; treatment access; and treatment effectiveness. Prevalent substances of abuse are examined, as are issues facing special populations.




Anxiety and Substance Use Disorders


Book Description

Disorders of anxiety and substance use are, for some reason, rarely treated in an integrated fashion by professionals. This timely volume addresses this glaring omission with dispatches from the frontlines of research and treatment. Thirty-four international experts offer findings, theories, and intervention strategies for this common form of dual disorder, across a range of substances and of anxiety disorders, to give the reader comprehensive knowledge in a practical format.







Substance Abuse During Pregnancy, An Issue of Obstetrics and Gynecology Clinics


Book Description

This issue of Obstetrics and Gynecology Clinics of North America deals with the timely subject of substance use during pregnancy. Alcohol, tobacco, and illicit drug use is prevalent among reproductive-age women. Even though a reduction in use often occurs during pregnancy, many women continue to use substances until a pregnancy is either actually diagnosed or well underway.This issue consists of a well-qualified team of obstetricians-gynecologists, psychiatrists, and family physicians, focusing on various issues related directly to pregnancies complicated by substance use. Topics of interest include epidemiology and screening for hazardous and harmful substance use, teratogenic risks, psychiatric comorbidities, comprehensive treatment approaches before and after delivery, fetal surveillance, and team-based perinatal management. Particularly new information relates to prescribing buprenorphine, neonatal abstinence syndrome, and adolescent substance use.